Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Cross-border transactions are becoming increasingly common in today's globalized economy, and the cannabis industry is no exception. Vicente LLP uses its deep-rooted understanding of the marijuana and hemp space to provide clients with the local and international advice they need to close deals across borders, currencies, and cultures.
The international cannabis policy landscape is shifting quickly. At least 30 countries have legalized some form of medical cannabis, and several have legalized cannabis for adult use. Vicente LLP tracks these developments closely, and we have assisted government officials and organizations around the world with their development of cannabis policies. We employ a cross-disciplinary approach that borrows from several of our firm’s practice areas — including corporate, government and policy, hemp and cannabinoids, banking and financial, licensing, and regulatory compliance — to help businesses and investors successfully engage in a variety of cross-border transactions.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
By Charles Alovisetti
Jan 25, 2021
Like anything in the cannabis industry, getting a debt deal done requires navigating unique regulatory challenges. Here are seven regulatory considerations that cannabis borrowers and lenders should keep in mind when pursuing a debt transaction.
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian
Sep 18, 2020
Raising private capital continues to be a challenge for the nascent cannabis industry, but there are proactive steps companies can take to maximize the chance of a successful raise.